Desire and disappointment: Adolescent psychotropic treatment and adherence

Anthropology and Medicine

Volumn 17, Issue 2, 2010, Pages 159-172

  Longhofer, Jeffrey ^a   Floersch, Jerry ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

adolescent psychotropic treatment; biomedicine; cultural psychiatry; explanatory models; illness meaning; medical anthropology

Indexed keywords

ANTIDEPRESSANT AGENT; LAMOTRIGINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; QUETIAPINE;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; DESIRE; DRUG DOSE INCREASE; FEMALE; HUMAN; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH CARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE;

ADOLESCENT; ATTITUDE TO HEALTH; EMOTIONS; HUMANS; MEDICATION ADHERENCE; MENTAL DISORDERS; MOTIVATION; PARENTS; PSYCHOTROPIC DRUGS; SOCIAL ENVIRONMENT;

EID: 77955875024     PISSN: 13648470     EISSN: 14692910     Source Type: Journal    
DOI: 10.1080/13648470.2010.493599     Document Type: Article

References (73)

1. Applbaum, Kalman. 2009a. Getting to yes: Corporate power and the creation of a psychopharmaceutical blockbuster. Culture, Medicine and Psychiatry 33: 185-215.
2. Applbaum, Kalman. 2009b. 'Consumers are patients!' Shared decision-making and treatment non-compliance as business opportunity. Transcultural Psychiatry 46, no.1: 107-130
3. Barber, Charles. 2008. Comfortably numb: How psychiatry is medicating a nation. New York: Vintage.
4. Biehl, João. 2004. Life of the mind: The interface of psychopharmaceuticals, domestic economies, and social abandonment. American Ethnologist 31, no.4: 475-496
5. Biehl, João, and Amy Moran-Thomas. 2009. Symptom: Subjectivities, social ills, technologies. Annual Review of Anthropology 38, no.1: 267-288
6. Blader, Joseph C., and Gabrielle A. Carlson. 2007. Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004. Biological Psychiatry 62, no.2: 107-114.
7. Burston, Daniel. 2006. Diagnosis, drugs and bipolar disorder in children. In No child left different, ed. Sharna Olfman, 121-140 Westport, CT: Praeger Press.
8. Carpenter-Song, Elizabeth. 2009. Children's sense of self in relation to clinical processes: Portraits of pharmaceutical transformation. Ethos 37, no.3: 257-281
9. Critser, Greg. 2005. Generation rx: How prescription drugs are altering American lives, minds, and bodies. New York: Mariner Books.
10. Daley, Tamara C., and Thomas S. Weisner. 2003. 'I speak a different dialect': Teen explanatory models of difference and disability. Medical Anthropology Quarterly 17, no.1: 25-48.
11. Daly, Jeffrey, M., and Timothy Wilens. 1998. The use of tricyclic antidepressants in children and adolescents. Child and Adolescent Psychopharmacology 45, no.5: 1123-1135
12. Diller, Lawrence. 2006. The last normal child: Essays on the intersection of kids, culture, and psychiatric drugs. Westport, CT: Praeger Press.
13. Ecks, Stefan. 2005. Pharmaceutical citizenship: Antidepressant marketing and the promise of demarginalization in India. Anthropology and Medicine 12, no.3: 239-254
14. Evans, Dylan. 1996. An introductory dictionary of Lacanian psychoanalysis. New York: Routledge
15. . Farah, Martha, J., Judy Illes, Robert Cook-Deegan, Robert Gardner, Eric Kandel, Patricia King, Eric Parens, Barbara Sahakian, and Paul Root Wolpe. 2004. Enhancement: What can we do and what should we do? Neurocognitive. Science and Society 5: 421-425
16. Floersch, Jerry, Jeffrey Longhofer, Derrick Kranke, and Lisa Townsend. 2010. Integrating thematic, grounded theory, and narrative analysis: A case study of adolescent psychotropic treatment. Qualitative Social Work 9, no.2: 1-19.
17. Floersch, Jerry, Lisa Townsend, Jeffrey Longhofer, Michelle Munson, Vicki Winbush, Derek Kranke, Rachel Faber, Jeremy Thomas, Janis H. Jenkins, and Robert L. Findling. 2009. Adolescent experience of psychotropic treatment. Transcultural Psychiatry 46, no.1: 157-179
18. Forlini, Cynthia, and Eric Racine. 2009. Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. Medical Ethics 102, no.9.
19. Furman, Robert. 1998. On symptom diagnosis. Child Analysis 9: 170-194
20. Greene, Jeremy A. 2004. Therapeutic infidelities: 'Noncompliance' enters the medical literature, 1955-1975. Social History of Medicine 17, no.3: 327-343
21. Greene, Jeremy A. 2008. Prescribing by numbers: Drugs and the definition of disease. Baltimore: The Johns Hopkins University Press.
22. Harris, Gardiner. 2009. Pfizer pays $2.3 billion to settle marketing case. New York Times, September 3: B4.
23. Healy, David. 1997. The anti-depressant era. Cambridge, MA: Harvard University Press.
24. Healy, David. 2008. Mania: A short history of bipolar disorder. Baltimore: Johns Hopkins University Press.
25. Healy, David, and Joanna Le Noury. 2007. Pediatric bipolar disorder: An object of study in the creation of an illness. International Journal of Risk and Safety in Medicine 19: 209-221
26. Hogan, Thomas P., George A. Awad and Robin Eastwood. 1983. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminate validity. Psychological Medicine 13: 177-183
27. Iversen, Leslie. 2008. Speed, ecstasy, Ritalin: The science of amphetamines. Oxford: Oxford University Press.
28. James, Allison. 2007. Giving voice to children's voices: Practices and problems, pitfalls and potentials. American Anthropologist 109, no.2: 261-272
29. Jenkins, Janis H. 1997. Subjective experience of persistent psychiatric disorder: Schizophrenia and depression among U.S. Latinos and Euro-Americans. British Journal of Psychiatry 171: 20-25
30. Jenkins, Janis H., Milton E. Strauss, Elizabeth A. Carpenter, Dawn Miller, Jerry Floersch, and Martha Sajatovic. 2005. Subjective experience of recovery from schizophreniarelated disorders and atypical antipsychotics. The International Journal Social Psychiatry 51, no.3: 211-227
31. Kirn, Walter. 2009. A pharmacological education. New York Times, September 6, sec MM9.
32. Kulick, Don. 2003. Language and desire. In The handbook of language and gender, ed. Janet Holmes and Miriam Meyerhoff, 119-141 Malden, MA: Blackwell.
33. Lacan, Jacques. 1966. É crits. Paris: Seuil.
34. Lacan, Jacques. 1988. Book II. The ego in Freud's theory and in the technique of psychoanlaysis, 1954-1955, Chapter 19. Cambridge: Cambridge University Press.
35. Lakoff, Andrew. 2005. Pharmaceutical reason. Cambridge: Cambridge University Press.
36. Lewontin, Richard, and Richard Levin. 2007. Biology under the influence: Dialectical essays on the coevolution of nature and society. New York: Monthly Review Press.
37. Longhofer, Jeffrey L., and Jerry Floersch. 2004. The phenomenological practice gap: Practice guidelines, evaluation, and clinical judgment (book). Qualitative Social Work 3, no.4: 483-486
38. Longhofer, Jeffrey, Jerry Floersch, and Janis H. Jenkins. 2003. The social grid of community medication management. The American Journal of Orthopsychiatry 73, no.1: 24-34.
39. Lyons, John S., James C. MacIntyre, Michael Lee, E., Sharon Carpinello, Michael P. Zuber, and Marcia L. Fazio. 2004. Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system. Community Mental Health Journal 40, no.2: 110-118
40. Mallett, Christopher. 2006. Behaviorally-based disorders: The historical social construction of youths' most prevalent psychiatric diagnoses. History of Psychiatry 17, no.4: 437-460
41. Manic-Depression.net. Bipolar disorder and heredity. http://www.manic- depression.net/ bipolar/bipolar-disorder-and-heredity.htm.
42. Mattingly, Cheryl. 1998. Healing dramas and clinical plots: The narrative structure of experience. Cambridge: Cambridge University Press.
43. Mattingly, Cheryl, and Linda C. Garro. 2000. Narrative and the cultural construction of illness and healing. Berkeley: University of California Press.
44. McDaniel, Kris, and Ben Bradley. 2008. Desires. Mind 117, no.466: 267-302.
45. Miller, Carol Marbin. 2009. Child-welfare panel: Drugs misused on foster kids. Miami Herald, August 8.
46. Moerman, Daniel. 2002. Meaning, medicine and the 'placebo effect'. Cambridge: Cambridge University Press.
47. Moynihan, Ray, and Alan Cassals. 2005. Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients. New York: Nation Books.
48. Oldani, Michael J. 2009. Uncanny scripts: Understanding pharmaceutical emplotment in the aboriginal context. Transcultural Psychiatry 461, no.1: 131-156
49. Olfman, Sharna, ed. 2006. No child left different. Westport, CT: Praeger Press.
50. Olfson, M., C. Blanco, L. Liu, C. Moreno, and G. Laje. 2006. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63, no.6: 679-685
51. Petersen, Melody. 2009. Our daily meds: How the pharmaceutical companies transformed themselves into slick marketing machines and hooked the nation on prescription drugs. New York: Picador.
52. Petryna, Adriana. 2002. Life exposed: Biological citizens after Chernobyl. Princeton, NJ: Princeton University Press.
53. Phillips, Tania, Gill Salmon, and C. James Anthony. 2003. Prescribing practices in child and adolescent psychiatry: Change over time 1993-2000. Child and Adolescent Mental Health 8, no.1: 23-28
54. Railton, Peter. 2003. Facts, values and norms: Essays toward a morality of consequence. Cambridge: Cambridge University Press.
55. Rasmussen, Nicolas. 2008. On speed: The many lives of amphetamine. New York: New York University Press.
56. Rose, Nikolas. 2003. Neurochemical selves. Society 41, no.1: 46-59.
57. Rose, Stephen. 2005. The future of the brain: The promise and perils of tomorrow's neuroscience. New York: Oxford University Press.
58. Rubin, Jeffrey. 2007. Be careful what you wish for: Going beyond compliance. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 35, no.2: 203-210
59. Schafer, Roy. 2003. Bad feelings: Selected psychoanalytic essays. New York: Karnac.
60. Smith, Michael. 2004. Instrumental desires, instrumental rationality. Supplement to the Proceedings of the Aristotelian Society 78, no.1: 93-109.
61. Spielmans, Glen. 2009. The promotion of olanzapine in primary care: An examination of internal industry documents. Social Science and Medicine 69, no.1: 14-20.
62. Thomas, Cindy Parks, Peter Conrad, Rosemary Casler, and Elizabeth Goodman. 2006. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatric Services 57: 63-69
63. Townsend, Lisa, Jerry Floersch, and Robert L. Findling. 2010. The conceptual adequacy of the drug attitude inventory for measuring youth attitudes toward psychotropic medications: A mixed method evaluation. Journal of Mixed Methods Research 4, no.1: 32-55.
64. Valenstein, Elliot. 1998. Blaming the brain: The truth about drugs and mental health. New York: Free Press.
65. Valenstein, Elliot. 2005. The war of the soups and the sparks: The discovery of neurotransmitters and the dispute over how nerves communicate. New York: Columbia University Press.
66. Varley, C.K. 2003. Psychopharmacological treatment of major depressive disorder in children and adolescents. Journal of the American Medical Association 290, no.8: 1091-1093
67. Verhaege, Paul. 2004. On being normal and other disorders: A manual for clinical psychodiagnostics. New York: Other Press.
68. Whitmarsh, Ian. 2009. Medical schismogenics: Compliance and 'culture' in Caribbean biomedicine. Anthropological Quarterly 82, no.2: 447-475
69. Wilson, Mitchell. 1993. DSM-III and the transformation of American psychiatry: A history. American Journal of Psychiatry 150, no.3: 399-410.
70. Wolraich, Mark L. 2003. Annotation: The use of psychotropic medications in children: An American view. Journal of Child Psychology and Psychiatry 42, no.2: 159-168
71. Wozniak, Janet. 2003. Pediatric bipolar disorder: The new perspective on severe mood dysfunction in children. Journal of Child and Adolescent Psychopharmacology 13, no.4: 449-451
72. Zito, Julie Magno, Daniel J. Safer, Susan DosReis, Myde Boles, and Frances Lynch. 2000. Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association 283, no.8: 1025-1030
73. Zito, Julie M., Daniel J. Safer, Devadatta Sai, James F. Gardner, Diane Thomas, Phyllis Coombes, Melissa Dubowski, and Maria Mendez-Lewis. 2008. Psychotropic medication patterns among youth in foster care. Pediatrics 121, no.1: e157-163.